IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

Scientific - Published in Current Biology
Identification of genes that cause resistance to treatment of the pathogenic fungus Candida
Innovation
The MAF test® for patients with breast cancer gets closer to the market
Institutional
The future of cancer research 
to be debated in Barcelona
Dr. Roger Gomis (IRB Barcelona researcher, Inbiomotion Founder and CSO) and Dr. Joël Jean-Mairet (Inbiomotion Executive Chaiman)
Innovation
IRB Barcelona spin-off Inbiomotion’s MAF Test® selects breast cancer patients benefitting from adjuvant clodronate, significantly improving their overall survival
Innovation
Nuage Therapeutics, the spin-off from IRB Barcelona and ICREA, is launched with the support of Asabys
Salvador Aznar Beniath, IRB Barcelona
Scientific - Published in Science Advances
The circadian rhythm of the liver is regulated by muscle activity
Institutional
The PERSIST-SEQ consortium kicks off to overcome resistance to cancer treatments
Community
A new PI in town: An interview with Dr. Jordi Duran, new Group Leader at the IQS
Scientific - Published in Nature Communications
Scientists reveal how the impact of chemotherapy on healthy cells affects the development of blood cells

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog